Tag: psychedelic drugs market analysis

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Psychedelic Drugs Market Expected to Be in 2029?

The market size for psychedelic drugs has experienced aggressive expansion over the recent past. The market, which was valued at $5.56 billion in 2024, is projected to increase to $6.33 billion in 2025, recording a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the historic period include changes in regulatory systems, a surge in mental health consciousness, as well as evolving public attitudes.

It is anticipated that the psychedelic drugs market will experience swift expansion in the coming years, projected to hit “$11.68 billion by 2029 with a compound annual growth rate (CAGR) of 16.5%.” This forthcoming growth period will be driven by factors such as advances in drug development, broader therapeutic applications, increased acceptance within the medical profession, changes in public policies, and a response to the mental health crisis. Key trends that will emerge in this forecast period encompass increased emphasis on education and public awareness, legal changes and regulatory advancements, the broadening array of psychedelic compounds, and treatment approaches orientated around the patient.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

What Are The Contributors To Demand In The Psychedelic Drugs Market?

The escalation in mental illness incidences is projected to fuel the expansion of the psychedelic drugs market in the future. Mental illnesses are health issues characterized by alterations in feelings, cognition, or behavior. These illnesses encompass discomfort and post-traumatic stress disorder. Psychedelic drugs, which are employed to manage depression and post-traumatic stress disorder, can reduce mental illnesses with consistent use. For example, the National Centre for Social Research, a social research institution based in the UK, reported in November 2022 that the percentage of 17- to 19-year-olds suspected of having a mental disorder rose from 17.4% in 2021 to 25.7% in 2022. Thus, the swelling number of mental illness cases is stimulating the growth of the psychedelic drugs market.

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Future Market Trends Are Projected For The Psychedelic Drugs Industry?

Leading entities in the psychedelic drugs market are concentrating their efforts on the development of novel products such as ketamine. They aim to enhance therapeutic results for mental health disorders, broaden patient access to these treatments, and investigate the potential uses of psychedelic substances for conditions like depression, anxiety, PTSD, and substance use disorders. Ketamine, known for its distinctive anesthetic and analgesic properties, is now being studied for its swift antidepressant effects, particularly in treating severe depression and PTSD. In March 2022, for example, the traditional American company Husch Blackwell established the Psychedelics and Emerging Therapies Practice Group. The aim of this practice group is to support pioneers in their quest to research, develop, and bring to market cutting-edge psychedelic-based therapies. The group is made up of a diversified team of legal experts who specialize in navigating the intricate laws associated with these often Schedule I classified controlled substances under U.S. federal law. This status poses significant regulatory obstacles that could impede research and development ventures.

Who Are The Top-Ranked Companies In The Psychedelic Drugs Market Today?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

How Is Psychedelic Drugs Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Psychedelic Drugs Market Size From 2025 to 2034?

The size of the market for psychedelic drugs has seen a swift expansion in the past few years. Its growth is projected to surge, moving from $5.56 billion in 2024 to $6.33 billion in 2025. This represents a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth witnessed in the historic period include changes in the regulatory environment, heightened awareness about mental health, and evolving public viewpoints.

The market size for psychedelic drugs is projected to experience exponential growth in the upcoming years, expanding to an estimate of $11.68 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 16.5%. This surge in growth during the projection period can be attributed to several factors such as progress in drug development, broadening of therapeutic applications, the increasing acceptance within the medical fraternity, changes in public policy, and responses to mental health crises. The forecast period will also witness significant trends such as a concentration on educating the public and increasing awareness, evolution in legal and regulatory factors, the proliferation of psychedelic compounds, and an emphasis on patient-focused treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?

The escalation in mental illness instances is projected to spur the expansion of the psychedelic drugs market in the future. Mental illnesses denote health conditions characterized by variations in feelings, cognition, or conduct; they encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs, used for treating depression and PTSD, can reduce the occurrence of mental illnesses with regular use. To illustrate, per the November 2022 data from the National Centre for Social Research, London-based social research institute indicated that the count of 17 to 19-year-olds suspected of having a mental disorder escalated from 17.4% in 2021 to 25.7% in 2022. Consequently, the escalating prevalence of mental health disorders is fuelling the growth of the psychedelic drugs market.

Which Primary Segments of the Psychedelic Drugs Market Are Driving Growth and Industry Transformations?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?# Market?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Psychedelic Drugs Industry Dynamics?

Leading organizations in the psychedelic drugs industry are concentrating their efforts on ground-breaking products like ketamine to enhance treatment results for mental health issues, augment patient access to therapy, and delve into new uses for psychedelic substances in areas such as depression, anxiety, PTSD, and substance use disorders. Known for its dissociative characteristics, ketamine is also used as an anesthetic and analgesic and is being studied for its instantaneous antidepressant effects in managing severe conditions like depression and PTSD. For example, Husch Blackwell, a conventional company headquartered in the US, introduced the Psychedelics and Emerging Therapies Practice Group in March 2022. This group is planned to support innovators in the research, development, and marketing of novel therapies derived from psychedelics. It includes a multidisciplinary group of solicitors proficient in navigating the complex legal environment surrounding these substances, often categorized as Schedule I controlled substances under U.S. federal law. This categorization presents considerable regulatory obstacles which can slow down research and development.

View the full report here:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

What Parameters Are Used to Define the Psychedelic Drugs Market?

Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All the senses are affected by psychedelics, which change a person’s thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamide (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Psychedelic Drugs Market Size From 2025 to 2034?

The size of the market for psychedelic drugs has seen a swift expansion in the past few years. Its growth is projected to surge, moving from $5.56 billion in 2024 to $6.33 billion in 2025. This represents a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth witnessed in the historic period include changes in the regulatory environment, heightened awareness about mental health, and evolving public viewpoints.

The market size for psychedelic drugs is projected to experience exponential growth in the upcoming years, expanding to an estimate of $11.68 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 16.5%. This surge in growth during the projection period can be attributed to several factors such as progress in drug development, broadening of therapeutic applications, the increasing acceptance within the medical fraternity, changes in public policy, and responses to mental health crises. The forecast period will also witness significant trends such as a concentration on educating the public and increasing awareness, evolution in legal and regulatory factors, the proliferation of psychedelic compounds, and an emphasis on patient-focused treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?

The escalation in mental illness instances is projected to spur the expansion of the psychedelic drugs market in the future. Mental illnesses denote health conditions characterized by variations in feelings, cognition, or conduct; they encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs, used for treating depression and PTSD, can reduce the occurrence of mental illnesses with regular use. To illustrate, per the November 2022 data from the National Centre for Social Research, London-based social research institute indicated that the count of 17 to 19-year-olds suspected of having a mental disorder escalated from 17.4% in 2021 to 25.7% in 2022. Consequently, the escalating prevalence of mental health disorders is fuelling the growth of the psychedelic drugs market.

Which Primary Segments of the Psychedelic Drugs Market Are Driving Growth and Industry Transformations?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?# Market?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Psychedelic Drugs Industry Dynamics?

Leading organizations in the psychedelic drugs industry are concentrating their efforts on ground-breaking products like ketamine to enhance treatment results for mental health issues, augment patient access to therapy, and delve into new uses for psychedelic substances in areas such as depression, anxiety, PTSD, and substance use disorders. Known for its dissociative characteristics, ketamine is also used as an anesthetic and analgesic and is being studied for its instantaneous antidepressant effects in managing severe conditions like depression and PTSD. For example, Husch Blackwell, a conventional company headquartered in the US, introduced the Psychedelics and Emerging Therapies Practice Group in March 2022. This group is planned to support innovators in the research, development, and marketing of novel therapies derived from psychedelics. It includes a multidisciplinary group of solicitors proficient in navigating the complex legal environment surrounding these substances, often categorized as Schedule I controlled substances under U.S. federal law. This categorization presents considerable regulatory obstacles which can slow down research and development.

View the full report here:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

What Parameters Are Used to Define the Psychedelic Drugs Market?

Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All the senses are affected by psychedelics, which change a person’s thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamide (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Projections for the CAGR of the Psychedelic Drugs Market Size From 2025 to 2034?#_x000D_

The size of the market for psychedelic drugs has seen a swift expansion in the past few years. Its growth is projected to surge, moving from $5.56 billion in 2024 to $6.33 billion in 2025. This represents a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth witnessed in the historic period include changes in the regulatory environment, heightened awareness about mental health, and evolving public viewpoints._x000D_

_x000D_

The market size for psychedelic drugs is projected to experience exponential growth in the upcoming years, expanding to an estimate of $11.68 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 16.5%. This surge in growth during the projection period can be attributed to several factors such as progress in drug development, broadening of therapeutic applications, the increasing acceptance within the medical fraternity, changes in public policy, and responses to mental health crises. The forecast period will also witness significant trends such as a concentration on educating the public and increasing awareness, evolution in legal and regulatory factors, the proliferation of psychedelic compounds, and an emphasis on patient-focused treatments._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?#_x000D_

The escalation in mental illness instances is projected to spur the expansion of the psychedelic drugs market in the future. Mental illnesses denote health conditions characterized by variations in feelings, cognition, or conduct; they encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs, used for treating depression and PTSD, can reduce the occurrence of mental illnesses with regular use. To illustrate, per the November 2022 data from the National Centre for Social Research, London-based social research institute indicated that the count of 17 to 19-year-olds suspected of having a mental disorder escalated from 17.4% in 2021 to 25.7% in 2022. Consequently, the escalating prevalence of mental health disorders is fuelling the growth of the psychedelic drugs market._x000D_

_x000D_

#Which Primary Segments of the Psychedelic Drugs Market Are Driving Growth and Industry Transformations?#_x000D_

The psychedelic drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia_x000D_

2) By Disease Indication: Depression, PTSD_x000D_

3) By Origin: Natural, Synthetic_x000D_

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders_x000D_

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_

_x000D_

Subsegments:_x000D_

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters_x000D_

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable_x000D_

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid_x000D_

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules_x000D_

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?# Market?#_x000D_

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Psychedelic Drugs Industry Dynamics?#_x000D_

Leading organizations in the psychedelic drugs industry are concentrating their efforts on ground-breaking products like ketamine to enhance treatment results for mental health issues, augment patient access to therapy, and delve into new uses for psychedelic substances in areas such as depression, anxiety, PTSD, and substance use disorders. Known for its dissociative characteristics, ketamine is also used as an anesthetic and analgesic and is being studied for its instantaneous antidepressant effects in managing severe conditions like depression and PTSD. For example, Husch Blackwell, a conventional company headquartered in the US, introduced the Psychedelics and Emerging Therapies Practice Group in March 2022. This group is planned to support innovators in the research, development, and marketing of novel therapies derived from psychedelics. It includes a multidisciplinary group of solicitors proficient in navigating the complex legal environment surrounding these substances, often categorized as Schedule I controlled substances under U.S. federal law. This categorization presents considerable regulatory obstacles which can slow down research and development._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Psychedelic Drugs Market?#_x000D_

Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All the senses are affected by psychedelics, which change a person’s thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamide (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Psychedelic Drugs Market from 2024 to 2025?

In recent times, the market size of psychedelic drugs has seen significant growth. The market, which was valued at $5.56 billion in 2024, is expected to expand to $6.39 billion in 2025, with a compound annual growth rate (CAGR) of 14.9%. This increase throughout the historical period can be credited to changes in regulatory frameworks, enhanced awareness of mental health and a shift in public opinion.

What Is the Projected Market Size of the Psychedelic Drugs Market?

The market size of psychedelic drugs is projected to witness fast-paced progression in the forthcoming years. By 2029, this market is estimated to reach a valuation of $11.93 billion, escalating at a compound annual growth rate (CAGR) of 16.9%. Factors contributing to growth within the forecast period include improvements in drug formulation, the enlargement of therapeutic uses, greater endorsement from the medical field, shifts in public policy, and reaction to the mental health crisis. Key trends throughout this period will revolve around raising public awareness and education, legal and regulatory shifts, the broadening of psychedelic compounds, and treatment approaches centered on the patient.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Who are the Major Competitors in the Psychedelic Drugs Market Outlook?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

What Is Fueling Growth in the Psychedelic Drugs Market?

The rise in mental health disorders is predicted to spur the expansion of the psychedelic drugs industry. These health disorders involve changes in emotions, cognition, or behavior, including conditions like distress and post-traumatic stress disorder. Psychedelic medications, utilized for treating depression and post-traumatic stress disorder, can lessen mental illnesses with consistent use. For example, the National Centre for Social Research, an established UK social research institute, reported in November 2022 that the ratio of 17- to 19-year-olds suspected to have a mental disorder increased from 17.4% in 2021 to 25.7% in 2022. Therefore, the escalating rate of mental illness cases is acting as a catalyst for the growth of the psychedelic drugs industry.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

Which Psychedelic Drugs Market Segments Are Growing the Fastest?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Which Industry Trends Are Shaping the Future of the Psychedelic Drugs Market?

Primary firms within the psychedelic drugs market are concentrating their efforts on pioneering items such as ketamine, with the aim of advancing treatment results for mental health conditions, increasing treatment availability for patients, and investigating new uses for psychedelic components in areas including depression, anxiety, PTSD, and substance use disorders. Ketamine, notable for its dissociative features, is a medical drug used as an anesthetic and painkiller. It is also being scrutinized for its fast-acting antidepressant effects in managing severe depression and PTSD. For instance, Husch Blackwell, a conventional company based in the U.S., rolled out the Psychedelics and Emerging Therapies Practice Group in March 2022. The group’s purpose is to support innovators in their research, development, and commercialization process regarding new psychedelic-based therapies. It consists of an interdisciplinary lawyers’ team proficient in navigating the intricate legal environment tied to these substances, typically classified as Schedule I controlled substances under U.S. federal law. This classification creates substantial regulatory obstacles capable of hampering research and development activities.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Countries Are Leading the Psychedelic Drugs Market?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

This Report Delivers Insight On:

1. How big is the psychedelic drugs market, and how is it changing globally?

2. Who are the major companies in the psychedelic drugs market, and how are they performing?

3. What are the key opportunities and risks in the psychedelic drugs market right now?

4. Which products or customer segments are growing the most in the psychedelic drugs market?

5. What factors are helping or slowing down the growth of the psychedelic drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of thePsychedelic Drugs Market?

The escalating number of mental illness cases is predicted to stimulate the expansion of the psychedelic drugs market. These health-related conditions, referred to as mental illnesses, are marked by alterations in emotional, thought, or behavioral patterns and encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs are used as a treatment for depression and post-traumatic stress disorder, with their consistent use helping to reduce mental illnesses. This is exemplified by data from the National Centre for Social Research in UK, which revealed that the ratio of 17- to 19-year-olds suspected of having a mental disorder shot up from 17.4% in 2021 to 25.7% in 2022. Consequently, the rise in mental illness cases is fuelling the psychedelic drugs market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

#What is the Growth Potential of the Psychedelic Drugs Market, and How Will It Perform by 2034?

The market size of psychedelic drugs has seen a swift expansion in the past few years. It is set to balloon from $5.56 billion in 2024 to $6.39 billion in 2025, at a compound annual growth rate (CAGR) of 14.9%. The dramatic increase in the historic period is credited to changing governmental regulations, rise in awareness about mental health, and evolving public opinion.

Expectations are high for the psychedelic drugs market to experience a quick expansion in the upcoming years. The market size is projected to reach $11.93 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%. The growth can be credited to breakthroughs in drug research, broadening therapeutic uses, rising acceptance among medical professionals, changes in public policy, and reactions to the mental health crisis. The forecast period sees an emphasis on promoting education and public awareness, as well as key trends such as legal and regulatory progress, diversification in psychedelic substances, and a focus on treatment methods that prioritize the patient.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

Which Upcoming Market Trends and Innovations Are Set to Influence thePsychedelic Drugs Market’s Path Forward?

Key players in the psychedelic drugs market are concentrating on groundbreaking products like ketamine in a bid to bolster therapeutic results for mental health diseases, widen patient access to therapies, and delve into fresh uses for psychedelic substances in fields such as depression, anxiety, PTSD, and substance misuse disorders. Ketamine, famed for its dissociative characteristics, is a prescription medication traditionally used as an analgesic and anesthetic. It’s presently under investigation for its fast-acting antidepressant effects in treating serious depression and PTSD. For example, traditional US company Husch Blackwell unveiled the Psychedelics and Emerging Therapies Practice Group in March 2022. This group has a mandate to aid pioneers in studying, crafting, and unleashing innovative treatments built on psychedelics. It consists of a cross-disciplinary group of legal experts experienced in dealing with the intricate legalities associated with these substances, often designated as Schedule I controlled substances under U.S. federal legislation. This categorization introduces considerable regulatory obstacles that can obstruct research and development pursuits.

Who Are the Dominant Market Players Pushing the Boundaries of thePsychedelic Drugs Market?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

What Are the Core Segments of the Psychedelic Drugs Market, and How Do They Contribute to Growth?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

What Regions Are Dominating the Psychedelic Drugs Market Growth?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2025, By The Business Research Company:

Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soy-protein-global-market-report

Textured Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

Protein Inhibitors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the psychedelic drugs market right now?

The market size of psychedelic drugs has experienced swift expansion in recent years. The market is projected to expand from $5.56 billion in 2024 to $6.39 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.9%. The expansion during the historic period can be associated with transformations in regulatory scenarios, heightened consciousness about mental health, and evolving public viewpoint.

How fast Is the psychedelic drugs market expected to grow, and what’s its future value?

Get your psychedelic drugs market report here!

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

What are the leading drivers of growth in the psychedelic drugs market?

The escalation in instances of mental health issues is anticipated to spur the expansion of the psychedelic drugs market in the future. Mental health issues represent health scenarios marked by alterations in feelings, cognition, or conduct and encompass conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are employed to tackle depression and post-traumatic stress disorder, and their consistent consumption reduces mental disorders. For example, in November 2022, the National Centre for Social Research, a social research establishment in the UK, reported that the fraction of 17- to 19-year-olds suspected of having a mental disorder rose from 17.4% in 2021 to 25.7% in 2022. Consequently, the surge in the occurrences of mental health issues is propelling the growth of the psychedelic drugs market.

What are the key segments defining the psychedelic drugs market?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Who are the key players steering the development of the psychedelic drugs market?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

What emerging trends are influencing the growth of the psychedelic drugs market?

In the psychedelic drugs industry, prominent enterprises comprising Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, and Universal Ibogaine function vitally.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

Which regions are most influential in expanding the psychedelic drugs market?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Central Nervous System Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

Metabolic Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Respiratory Diseases Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Psychedelic Drugs Market Shape Industry Trends by 2034?

The market size of psychedelic drugs has witnessed accelerated expansion in the past few years. The market is projected to escalate from $5.56 billion in 2024, expanding to $6.39 billion in 2025, with a compound annual growth rate (CAGR) of 14.9%. The historical growth is credited to evolving regulatory frameworks, heightened awareness of mental health issues, and a transformation in the public’s viewpoint.

Anticipated to witness a surge in the coming years, the market size of psychedelic drugs is projected to reach $11.93 billion by 2029, escalating at a compound annual growth rate (CAGR) of 16.9%. The forecasted period’s growth is linked to progress in drug development, expansion in therapeutic uses, a rise in acceptance within the medical fraternity, shifts in public policy, and response to the mental health crisis. Prominent trends during the forecasted period are expected to revolve around education and public awareness, legal and regulatory changes, diversification in psychedelic compounds, and patient-focused treatment methodologies.

What Major Innovations Are Driving the Accelerated Growth of the psychedelic drugs Market?

The rise in mental health disorders is anticipated to spur the expansion of the psychedelic drugs market. These health disorders relate to alterations in feelings, cognition, or conduct, and encompass conditions such as distress and post-traumatic stress disorder. Psychedelic drugs, utilized for treating depression and PTSD, can reduce the rate of mental illnesses through regular use. For example, the National Centre for Social Research reported in November 2022 that the percentage of 17 to 19-year-olds suspected of having mental disorders in the UK escalated from 17.4% in 2021 to 25.7% in 2022. Therefore, the surge in mental illness cases is a key catalyst for the growth of the psychedelic drugs market.

Explore Comprehensive Insights Into The Global Psychedelic Drugs Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Who Are the Key Market Players Influencing the Growth of the Psychedelic Drugs Industry?

Major companies operating in the psychedelic drugs market include:

• Atai Life Sciences

• Cybin Inc.

• Mind Medicine Inc.

• Compass Pathways

• Seelos Therapeutics

What Key Market Trends Are Shaping the Future of the Psychedelic Drugs Industry?

Top businesses in the psychedelic drugs market are concentrating on pioneering products like ketamine, in order to augment therapeutic results in mental health disorders, increase the availability of treatments to patients, and probe into fresh uses for psychedelic substances in conditions such as depression, anxiety, PTSD, and substance addiction disorders. Ketamine is a well-known anesthesia and painkiller medication, notable for its dissociative aspects and its potential rapid antidepressant impacts in managing severe depression and PTSD. For example, in March 2022, Husch Blackwell, a traditional company in the United States, initiated the Psychedelics and Emerging Therapies Practice Group. This group is aimed to support innovators in the study, development, and commercialization of new therapies based on psychedelics. It encompasses a multidisciplinary squad of legal experts adept at steering through the involved legal milieu related to these substances, often tagged as Schedule I controlled substances under the U.S. federal law, a categorization that brings about substantial regulatory obstacles that can impede research and development activities.

Secure Your Global Psychedelic Drugs Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

What Are the Core Categories and Segments in the Psychedelic Drugs Market Driving Demand and Growth?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Which Regions Are Emerging as Leaders in the Psychedelic Drugs Market?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Psychedelic Drugs Market Defined Across Different Regions?

Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All the senses are affected by psychedelics, which change a person’s thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamide (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

Browse Through More Similar Reports By The Business Research Company:

Central Nervous System Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

Metabolic Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Respiratory Diseases Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: